After obtaining a PhD in Microbiology at the University of Aix-Marseille and an EMBA in Healthcare Management at the University of Lausanne, Joshua Armitano joined ExcellGene in 2020 to manage several cell line development program including a Covid antigen development project supported by CEPI.